Subject
Gastroenterology,Hepatology
Reference10 articles.
1. Review article: remission rates achievable by current therapies for inflammatory bowel disease
2. Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population
3. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/crohns-disease-developing-drugs-treatment. Accessed May 2023.
4. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/ulcerative-colitis-developing-drugs-treatment. Accessed May 2023.